Finance Watch: Prime Medicine Launches Second-Largest IPO In Second Half Of 2022
One Of Only Two $100m-Plus First-Time Offerings in H2
Public Company Edition: Prime Medicine raised $175m, making its offering the sixth-largest out of 19 biopharma IPOs in the US this year. Also, Oculis and AUM opted to go public via SPAC mergers, Insmed raised $775m from multiple financings and Dice capitalized on positive data with a $300m offering.
